Skip to main content

SOLACE - Strengthening the screening of Lung Cancer in Europe

Project ID
Project title

SOLACE - Strengthening the screening of Lung Cancer in Europe

Project manager, contact details
Márton Béres,
Academic supervisor, contact details
Prof. Dr. Imre Boncz,
Total project budget
12 156 677 EUR
Total budget of UP
8100 EUR
Project start date
Project end date
EIBIR gemeinnützige GmbH zur Förderung der Erforschung der biomedizinischen Bildgebung

Partner Organisations
Universitatsklinikum Heidelberg, Instytut Gruzlicy i Chorob Pluc, Lungs Europe, Medizinische Universitaet Wien, Orszagos Koranyi Pulmonologiai Intezet, Fakultní Thomayerova Nemocnice, Klinicki Bolnicki Centar Zagreb, Msb Medical School Berlin Gmbh, European Cancer Organisation, Medizinische Hochschule Hannover, Universita degli studi di Parma, Universitatea de medicina si farmacie carol davila din Bucuresti, Universitaet Hamburg¸ Assistance publique hopitaux de Paris, Royal College of Surgeons in Ireland, Hospices civils de Lyon, Universitaetsklinikum Hamburg-Eppendorf, Universitat Wien, Ustav zdravotnickych informaci a statistiky Ceske Republiky, Tartu ulikool, fondazione irccs istituto nazionale dei tumori, Deutsches Krebsforschungszentrum Heidelberg, Universidad de Navarra, Stichting radboud universitair medisch centrum, Helmholtz-zentrum Dresden-Rossendorf ev, Narodowy instytut zdrowia publicznego pzh – panstwowy instytut badawczy, lungenclinic Grosshansdorf gmbh, Universitatsklinikum Schleswig-Holstein, Ministry of Health, Opre Roma Egyesulet, Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz, Az Ormansag Egeszsegeer, Nonprofit Korlatolt Felelossegu Tarsasag. Neuro Ct. Pecsi Diagnosztikai Kozpont Kft.
General description

Early lung cancer detection in hard-to-reach social groups. Complex implementation of a lung cancer screening programme with low-dose CT screening to identify asymptomatic individuals at an early stage, allowing curative treatment while avoiding harm to those without the disease. To identify the target population, refer them for testing and perform screening by implementing a systematic, structured protocol.

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101101187.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Application monitoring